Table of Contents
Washington University Experience | MYELIN (IMMUNE-MEDIATED) | Sentinel & Steroid Rx Lesions | 3H2 Sentinel Lesion (Case 3 - 2nd Bx) CD20 3 copy
The neoplastic cells are strongly immunoreactive for the B-cell marker CD20. Notice that the background of necrotic cells (arrows) is also CD20 immunoreactive (CD20 IHC)
